Psychological Aspects of Hair Disorders: Consideration for Dermatologists, Cosmetologists, Aesthetic, and Plastic Surgeons

Overview

Journal Skin Appendage Disord

Specialty Dermatology

Date 2022 Jun 16

PMID 35707291

Authors

Cameron R Moattari

Mohammad Jafferany

Affiliations

Soon will be listed here.

Abstract

Hair loss disorders may cause considerable distress to patients. Although many do not pose a significant medical risk, the sociocultural importance of hair is substantial. Often the extent of hair loss does not correlate to the impact on psychosocial function, thus necessitating an individualized approach. Hair loss disorders are interrelated with mental health and at times exert significant psychological percussions, and therefore, providers should address both medical and psychological aspects of treatment. This review contains a discussion of the impact on quality of life of common hair loss disorders and the psychological approaches that providers may utilize to improve care. The incorporation of psychodermatology and psychotrichology in dermatology and psychiatry residency programs is of vital importance. Dermatology and psychiatry liaison clinics may prove useful in the treatment of these patients.

Citing Articles

Safety and feasibility of concomitant scalp cooling and limb cryocompression to prevent paclitaxel-induced alopecia and neuropathy.

Bandla A, Wong R, Santhanakrishnan P, Magarajah G, Yee Y, Ng W Support Care Cancer. 2025; 33(3):180.

PMID: 39937296 PMC: 11821790. DOI: 10.1007/s00520-024-08982-6.

The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis.

Almudimeegh A, Alajlan A, Alrasheed A, Alrasheed M, Alqahtani A, Idris R Medicine (Baltimore). 2025; 104(6):e41457.

PMID: 39928820 PMC: 11813004. DOI: 10.1097/MD.0000000000041457.

A Clinical Evaluation of the Safety, Efficacy, and Tolerability of the Soulflower Rosemary Redensyl Hair Growth Serum, Tetragain™, in Healthy Female Subjects for the Treatment of Alopecia: Promoting Hair Growth and Reducing Gray Hair.

Patel M, Tuli N, Patel N, Merja A Cureus. 2025; 17(1):e77066.

PMID: 39917132 PMC: 11800316. DOI: 10.7759/cureus.77066.

A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid function tests, zinc, copper, biotin, and selenium levels.

Durusu Turkoglu I, Turkoglu A, Soylu S, Gencer G, Duman R J Cosmet Dermatol. 2024; 23(12):4277-4284.

PMID: 39107936 PMC: 11626366. DOI: 10.1111/jocd.16512.

Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study.

Carton E, Blas A, Perret C, Le Bihan M Support Care Cancer. 2024; 32(7):410.

PMID: 38839667 PMC: 11153286. DOI: 10.1007/s00520-024-08579-z.

References

Bilgic O, Bilgic A, Bahali K, Bahali A, Gurkan A, Yilmaz S . Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata. J Eur Acad Dermatol Venereol. 2013; 28(11):1463-8. DOI: 10.1111/jdv.12315. View

Katoulis A, Christodoulou C, Liakou A, Kouris A, Korkoliakou P, Kaloudi E . Quality of life and psychosocial impact of scarring and non-scarring alopecia in women. J Dtsch Dermatol Ges. 2015; 13(2):137-42. DOI: 10.1111/ddg.12548. View

Yun S, Kim S . Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation. Dermatology. 2007; 215(1):36-40. DOI: 10.1159/000102031. View

Cho J, Choi E, Kim I, Im Y, Park Y, Lee S . Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients. Ann Oncol. 2014; 25(2):346-51. DOI: 10.1093/annonc/mdt476. View

Choi E, Kim I, Chang O, Kang D, Nam S, Lee J . Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology. 2014; 23(10):1103-10. DOI: 10.1002/pon.3531. View

Sinclair R . Alopecia areata and suicide of children. Med J Aust. 2014; 200(3):145. DOI: 10.5694/mja13.10895. View

Abedini H, Farshi S, Mirabzadeh A, Keshavarz S . Antidepressant effects of citalopram on treatment of alopecia areata in patients with major depressive disorder. J Dermatolog Treat. 2013; 25(2):153-5. DOI: 10.3109/09546634.2013.768761. View

Ito T . Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin Dev Immunol. 2013; 2013:348546. PMC: 3789320. DOI: 10.1155/2013/348546. View

Miteva M, Tosti A . Hair and scalp dermatoscopy. J Am Acad Dermatol. 2012; 67(5):1040-8. DOI: 10.1016/j.jaad.2012.02.013. View

10.

Pratt C, King Jr L, Messenger A, Christiano A, Sundberg J . Alopecia areata. Nat Rev Dis Primers. 2017; 3:17011. PMC: 5573125. DOI: 10.1038/nrdp.2017.11. View

11.

Odlaug B, Kim S, Grant J . Quality of life and clinical severity in pathological skin picking and trichotillomania. J Anxiety Disord. 2010; 24(8):823-9. DOI: 10.1016/j.janxdis.2010.06.004. View

12.

Bolduc C, Sperling L, Shapiro J . Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome. J Am Acad Dermatol. 2016; 75(6):1081-1099. DOI: 10.1016/j.jaad.2014.09.058. View

13.

Grant J, Chamberlain S . Trichotillomania. Am J Psychiatry. 2016; 173(9):868-74. PMC: 5328413. DOI: 10.1176/appi.ajp.2016.15111432. View

14.

Chu S, Chen Y, Tseng W, Lin M, Chen T, Hwang C . Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol. 2011; 166(3):525-31. DOI: 10.1111/j.1365-2133.2011.10714.x. View

15.

Arck P, Handjiski B, Peters E, Peter A, Hagen E, Fischer A . Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol. 2003; 162(3):803-14. PMC: 1868104. DOI: 10.1016/S0002-9440(10)63877-1. View

16.

Krasowska D, Szymanek M, Schwartz R, Myslinski W . Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors. J Am Acad Dermatol. 2006; 56(5):848-53. DOI: 10.1016/j.jaad.2006.10.020. View

17.

Bouwer C, Stein D . Trichobezoars in trichotillomania: case report and literature overview. Psychosom Med. 1998; 60(5):658-60. DOI: 10.1097/00006842-199809000-00025. View

18.

Pradhan P, DSouza M, Bade B, Thappa D, Chandrashekar L . Psychosocial impact of cicatricial alopecias. Indian J Dermatol. 2012; 56(6):684-8. PMC: 3276897. DOI: 10.4103/0019-5154.91829. View

19.

Messenger A, McKillop J, Farrant P, McDonagh A, Sladden M . British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012; 166(5):916-26. DOI: 10.1111/j.1365-2133.2012.10955.x. View

20.

Tan E, Martinka M, Ball N, Shapiro J . Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol. 2003; 50(1):25-32. DOI: 10.1016/j.jaad.2003.04.001. View